Browse by Poster Presenter

Skip to main content

ICPE 2023 Main banner

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

W
Wallace, Stuart

Johnson & Johnson
(209) Optimization-based Stable Balancing Weights vs. Propensity Score Weighting for Samples with High Covariate Imbalance
Stuart Wallace
Favorite
Wang, Echo

Merck & Co. Inc.
(252) Assessing validity of privacy-preserving synthetic patient data: A use case utilizing Israel COVID-19 real-world vaccine effectiveness study
Echo Wang
Favorite
Wang, Jiaxuan

Cytel Inc.
(133) Sensitivity Analyses to Assess Robustness of Estimates from Propensity Score Weighting in the Presence of Extremely Large Weights
Jiaxuan Wang
Favorite
Wang, Tiansheng

University of North Carolina at Chapel Hill, Department of Epidemiology
(147) Liraglutide and Risk of Dementia: Real World Evidence
Tiansheng Wang
Favorite
(214) Metformin and Risk of Dementia: Real World Evidence
Tiansheng Wang
Favorite
Wang, Wendy

University of Minnesota School of Public Health
(252) Percutaneous Left Atrial Appendage Occlusion and Risk of Stroke, Hospitalized Bleeding and Death in Medicare Beneficiaries with Atrial Fibrillation
Wendy Wang
Favorite
Wang, Yanning

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(A22) Utilization of antihypertensives before, during, and after pregnancy
Yanning Wang
Favorite
Wang, Yehua

University of Florida
(091) Assessing COVID-19’s impact on condition measurement in claims data
Yehua Wang
Favorite
(287) Assessing neonatal outcome misclassification using mother-infant dyad claims
Yehua Wang
Favorite
Webster-Clark, Michael

McGill University, Department of Epidemiology, Biostatistics, and Occupational Health
(213) Variable Selection for Transporting Estimates to Specific Target Populations
Michael Webster-Clark
Favorite
Weibel, Daniel

University Medical Center Utrecht
(047) Utilisation patterns of the COVID-19 mRNA vaccine (Comirnaty®) from the VAC4EU active safety surveillance study in five European countries
Daniel Weibel
Favorite
Wei, Li

Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
(039) RAAS Inhibitors-Related Adverse Drug Reactions and the Risk of Subsequent Cardiovascular Event and All-Cause Mortality: A Cohort Study in UK Primary Care
Li Wei
Favorite
Wei, Yu-Jung Jenny

The Ohio State University
(108) Trends in Concurrent Use of Central Nervous System-Active Medications Among Young-onset Dementia Patients
Yu-Jung Jenny Wei
Favorite
Wells, Karen

IQVIA
(175) Hereditary angioedema case validation using medical claims data from commercially insured patients
Karen Wells
Favorite
Wested, Jakob

Industrial Postdoc
(209) Assessing “neglected populations” in clinical trials – a pilot study of asthma medication use
Jakob Wested
Favorite
Wettermark, Björn

Uppsala university
(105) Impact of the COVID-19 pandemic on initiation of anti-diabetic drug consumption pattern in Sweden - An interrupted time series study
Björn Wettermark
Favorite
Weyermann, Maria

Niederrhein University of Applied Sciences
(029) Early retirement pensioners diagnosed with mental and behavioral disorders caused by psychoactive substances (ICD F11-19 block) in Germany - characterization and utilization of medical rehabilitation
Maria Weyermann
Favorite
White, Richard

UCB Pharma, Raleigh, USA
(174) An expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in US claims and UK primary care
Richard White
Favorite
Wiese, Andrew

Department of Health Policy, VUMC
(152) To whom results apply? Assessing the impact of extended continuous enrollment inclusion criteria in pharmacoepidemiologic studies of medication use in pregnancy
Andrew Wiese
Favorite
Wittwer, Nina

Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
(C42) Pharmacogenetic Testing in Switzerland: a Descriptive Study Using Swiss Claims Data
Nina Wittwer
Favorite
(C44) Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Children in Switzerland: a Descriptive Study Using Swiss Claims Data
Nina Wittwer
Favorite
Wong, Cherise

Pfizer
(260) Preliminary Findings from a Non-Interventional Post-Authorization Safety Study (PASS) for Active Safety Surveillance of Comirnaty Vaccine Recipients in the EU
Cherise Wong
Favorite
Wong, Joshua

Holmusk Inc., Singapore
(246) Real-world evidence on the burden of known side-effects of typical and atypical antipsychotic medications in patients with schizophrenia
Joshua Wong
Favorite
Woo, Jieun

Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea
(304) Effectiveness of COVID-19 Vaccine in SARs-CoV-2 Infected Patients with Chronic Kidney Disease
Jieun Woo
Favorite
Wu, Bingcao

Janssen Scientific Affairs, LLC
(188) Identifying Cytokine Release Syndrome in Retrospective Databases: A Performance Assessment of a Claims-Based Algorithm
Bingcao Wu
Favorite
Wu, Joanne

Pfizer Inc
(B30) Utility of Healthcare Professional (HCP) Surveys for Evaluating the Effectiveness of Additional Risk Minimization Measures (aRMMs): Experience from an HCP Survey Assessing the Effectiveness of aRMMs for Xeljanz® in Europe
Joanne Wu
Favorite
Wurst, Keele

GlaxoSmithKline
(127) Characteristics of Pregnant People Treated With Sotrovimab for COVID-19 from the COVID-19 International Drug Pregnancy Registry (COVID-PR)
Keele Wurst
Favorite
(134) Core Evidence Elements for generating medicine safety evidence for pregnancy using population-based data: Recommendations from IMI-ConcePTION
Keele Wurst
Favorite
Wyss, Richard

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
(275) Scalable natural language processing of electronic health records to supplement large-scale covariate adjustment in pharmacoepidemiologic studies
Richard Wyss
Favorite